InvestorsObserver
×
News Home

Is Vaxart Inc (VXRT) The Right Choice in Biotechnology?

Monday, September 21, 2020 11:44 AM | InvestorsObserver Analysts

Mentioned in this article

Is Vaxart Inc (VXRT) The Right Choice in Biotechnology?

Vaxart Inc (VXRT) is around the top of the Biotechnology industry according to InvestorsObserver. VXRT received an overall rating of 81, which means that it scores higher than 81 percent of all stocks. Vaxart Inc also achieved a score of 93 in the Biotechnology industry, putting it above 93 percent of Biotechnology stocks. Biotechnology is ranked 23 out of the 148 industries.

Overall Score - 81
VXRT has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on VXRT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 81 would rank higher than 81 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Vaxart Inc Stock Today?

Vaxart Inc (VXRT) stock has risen 8.5% while the S&P 500 is lower by -1.67% as of 11:41 AM on Monday, Sep 21. VXRT is up $0.70 from the previous closing price of $8.22 on volume of 23,715,904 shares. Over the past year the S&P 500 has gained 9.10% while VXRT is up 1615.38%. VXRT lost -$0.60 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Vaxart Inc (VXRT) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App